From: Prognostic significance of frailty status in patients with primary lung cancer
Character | HR (95% CI for HR) | p.value |
---|---|---|
agea | 0.99(0.99,1.00) | 0.054 |
gender | ||
female | ||
male | 1.073(0.943,1.22) | 0.284 |
BMIb | ||
I | ||
II | 0.9941(0.816,1.211) | 0.953 |
III | 0.9805(0.783,1.227) | 0.863 |
IV | 0.9920(0.795,1.237) | 0.943 |
Frailtyc | ||
Robust | ||
Pre-frail | 1.365(1.183,1.575) | < 0.001 |
Frail | 1.616(1.349,1.936) | < 0.001 |
TNM staged | ||
I | ||
II | 1.262(0.893,1.782) | 0.187 |
III | 2.516(1.875,3.378) | < 0.001 |
IV | 4.871(3.707,6.400) | < 0.001 |
Cancer histologye | ||
Adenocarcinoma | ||
Small cell | 0.957(0.785,1.167) | 0.666 |
Squamous cell | 1.017(0.853,1.213) | 0.852 |
Others | 0.956(0.822,1.111) | 0.557 |
Smoking historyf | ||
I | ||
II | 1.0492 0.9531 0.9076 1.213 | 0.516 |
III | 0.8237 1.2140 0.6177 1.098 | 0.187 |
IV | 1.1245 0.8893 0.8665 1.459 | 0.378 |
CCIg | ||
< 3 | ||
> = 3 | 5.751(4.741,6.975) | < 0.001 |
Surgery history | ||
no | ||
yes | 0.367(0.317,0.425) | < 0.001 |
Chemotherapy | ||
no | ||
yes | 2.42(1.973,2.969) | < 0.001 |
Radiotherapy | ||
no | ||
yes | 1.018(0.841,1.233) | 0.853 |
Target therapy | ||
no | ||
yes | 1.016(0.859,1.2) | 0.855 |